FDA Inspection 935859 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3007507466

The FDA completed an inspection of Octapharma Plasma, Inc. on July 23, 2015 in Des Moines, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 23, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Des Moines, IA (United States)